Makary Resigns as FDA Commissioner Following Policy Disputes
-
By
-
Kathryn Wighton
-
May 12, 2026
-
2 min
By
Kathryn Wighton
May 12, 2026
In a phase 2b trial, the highest dose produced an estimated 12% mean weight reduction vs 1% with placebo, although gastrointestinal adverse events were common.
July 16, 2026
Creatine's ATP-buffering trick isn't just for biceps. In mice, it juices up dendritic cells' energy supply, sharpening T-cell priming and shrinking tumors on daily injections. Human DCs got the memo too, at least in a dish. Early days, but a fun plot twist for gym-bag chemistry.
by Kerri Miller
July 8, 2026
The annual provisional report summarizes changes in mortality rates, demographic patterns, and leading causes of death during 2025.
July 13, 2026